TrialThe oncologist2024

Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results.

Zu-Guang Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.